Multiplexed testing for HIV and related bacterial and viral co-infections at the point-of-care: quo vadis?

Expert Rev Mol Diagn. 2015 Apr;15(4):463-9. doi: 10.1586/14737159.2015.1021335.

Abstract

Recently, there has been a paradigm shift toward an understanding of the need to screen select sub-populations for several sexually transmitted and blood-borne infections simultaneously, at one time with various rapid point-of-care (POC) technologies, rather than one infection at a time. This is an encouraging and promising change, however many contextual factors need to be considered before implementing such technologies. In this editorial, we highlight some challenges, issues and concerns regarding implementation, integration, and uptake of these technologies across global settings. However, careful planning and well thought out implementation plan that include investments in training health care professionals, improving test and treat algorithms, rapid protocols on communicating actionable results to providers, and timely action, will bring about the desired impact in patient's lives. This is especially true in settings where they stand to achieve the maximum desired public health and social impact.

Keywords: HIV and co-infections; multiplexed; point-of-care tests; simultaneous testing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coinfection*
  • HIV Infections / diagnosis*
  • HIV Infections / virology
  • Humans
  • Mass Screening / economics
  • Mass Screening / methods
  • Mass Screening / standards
  • Molecular Diagnostic Techniques / economics
  • Molecular Diagnostic Techniques / methods*
  • Molecular Diagnostic Techniques / standards
  • Point-of-Care Systems* / economics
  • Point-of-Care Systems* / standards